Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05195944 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Semaglutide vs Sitagliptin

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 140 to 58 Primary completion date: Apr 2024 to Dec 2026 · Primary endpoints: 1 to 2 · Completion date: Dec 2024 to Dec 2026 · 2 morev5 Show 5 more changesShow less
    • Primary completion date: Apr 2024 to Dec 2026
    • Primary endpoints: 1 to 2
    • Completion date: Dec 2024 to Dec 2026
    • Eligibility criteria expanded, about 93 words
    • Secondary endpoints: 2 to 5

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Not Yet Recruiting to Enrolling by Invitation Study sites: 0 to 1 · Start date changed from estimate of Aug 2022 to Oct 26, 2022v4 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 2022 to Oct 26, 2022
  3. Re-verified, no change to tracked fieldsv3
  4. Start date: Apr 2022 to Aug 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The effect of once daily dosing of oral Semaglutide versus once daily dosing Sitagliptin on glycemic control, body weight, and safety and tolerability will be compared in Liver Transplant Recipients with poorly-controlled Diabetes Mellitus.
Trial Details
NCT Number NCT05195944
Lead Sponsor University Health Network, Toronto
Collaborators: Novo Nordisk A/S
Conditions Liver Transplant; Complications, Diabetes Mellitus, NASH - Nonalcoholic Steatohepatitis, NAFLD
Enrollment 58 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov